The healthcare provider has added $25m to its original commitment of $25m for TMC Venture Fund, to be deployed over the next decade.

SAIC Motor’s Hengxu Capital helped allosteric drug developer Nutshell Therapeutics close a $40m round while cancer therapy developer Impact Therapeutics secured series D1 funding.

Aldi South, Rewe and Żabka joined investors including HP Tech Ventures, Qualcomm Ventures and Verizon Ventures in the autonomous retail technology developer's series B round.

Lunar expanded its series D round to $307m while RefleXion Medical raised $80m and Silent Eight raked in $40m.

Citi Ventures and SVB Capital have returned to back the real estate investment platform’s latest round together with lead investor SoftBank Vision Fund 2.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

Having found itself fighting a resolution from Crystal Amber to remove chairman Harry Rein, Allied Minds is exploring its options for the future.

Texas Medical Center has committed another $50m to its TMC Venture Fund, to be deployed over the next decade, adding to its original commitment of $25m in 2017.

Axa Venture Partners has returned to take part in the personalised health insurance service’s latest round, a year after it raised $28m in series D funding.

Animoca Brands and Untamed Planet have stepped out of the crypto and gaming sphere to invest in a genetic engineering startup looking to bring back the woolly mammoth.